SCHEMBL30108040

SCHEMBL30108040

CSc1nc(-c2ccco2)cc(-n2nnc3cc(Br)ccc32)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
HPGD P15428 7/20 0.42
KDM4E B2RXH2 7/20 0.42
HSD17B10 Q99714 5/20 0.42
TSHR P16473 4/20 0.42
GAA P10253 3/20 0.42
PIK3R1 P27986 2/20 0.40
PIK3CA P42336 2/20 0.40
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
POLB P06746 5/20 0.39
MAPT P10636 2/20 0.39
ALOX15 P16050 2/20 0.39
RECQL P46063 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PPARG P37231 2/20 0.39
RXFP1 Q9HBX9 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
NCOR2 Q9Y618 2/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108044 0.85 ALDH1A1 (0.40) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30108032 0.83 KDM4E (0.47) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30108073 0.82 LPL (0.40) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30107959 0.71 KDM4E (0.44) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30107951 0.71 PTGS1 (0.46) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30107973 0.71 KDM4E (0.46) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30108012 0.70 TSHR (0.58) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30108014 0.69 KDM4E (0.42) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30108013 0.68 HPGD (0.53) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30108023 0.68 PTGS1 (0.47) ALDH1A1HPGDKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed